Ethereum Classic (CRYPTO: ETC) is trading higher by 4.1% to $23.41 during Monday’s session, and is up 30% over the past week, following a new all-time high for Bitcoin. read more ​  ​Ethereum Classic (CRYPTO: ETC) is trading higher by 4.1% to $23.41 during Monday’s session, and is up 30% over the past week, following

read more ​  ​read more 

read more ​  ​read more 

read more ​  ​read more 

Following Donald Trump’s 2024 presidential win, Shiba Inu (CRYPTO: SHIB) has surged 67% to $0.00002837 over the past week, refle read more ​  ​Following Donald Trump’s 2024 presidential win, Shiba Inu (CRYPTO: SHIB) has surged 67% to $0.00002837 over the past week, refle read more 

Report highlights Trump’s potential pro-crypto policies but he can’t directly fire SEC chair Gensler. New appointees may ease regulatory landscape. read more ​  ​Report highlights Trump’s potential pro-crypto policies but he can’t directly fire SEC chair Gensler. New appointees may ease regulatory landscape. read more 

Taiwan Semiconductor faces new U.S. constraints, prohibiting advanced AI chip sales to China. Stock down, but company navigates between compliance and retaining business. read more ​  ​Taiwan Semiconductor faces new U.S. constraints, prohibiting advanced AI chip sales to China. Stock down, but company navigates between compliance and retaining business. read more 

CleanSpark Inc (NASDAQ:CLSK) shares are trading higher Monday alongside several Bitcoin (CRYPTO: BTC) mining stocks as the price of Bitcoin soars to new all-time highs. read more ​  ​CleanSpark Inc (NASDAQ:CLSK) shares are trading higher Monday alongside several Bitcoin (CRYPTO: BTC) mining stocks as the price of Bitcoin soars to new all-time highs. read more 

During his “My Take,” Monday, “Varney & Co.” host Stuart Varney addressed the anti-Trump “resistance” campaign, arguing the nation is not going to look kindly on “distraught Democrats” trying to destroy President-elect Trump’s second term. STUART VARNEY: There will be marches. There will be angry demonstrations. Maybe tearful outbursts.  The so-called “resistance” to Donald Trump,

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug. ​Read More